Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of StrokeHenry Ma, Geoffrey A. Donnan, Sami Curtze et al.|New England Journal of Medicine|2019Cited by 1k
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trialAtte Meretoja, Stephen M. Davis, Nawaf Yassi et al.|The Lancet Neurology|2020Cited by 144
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark Parsons, Vignan Yogendrakumar, Leonid Churilov et al.|The Lancet Neurology|2024Cited by 89
The Spot Sign and Tranexamic Acid on Preventing ICH Growth – AUStralasia Trial (STOP-AUST): Protocol of a Phase II Randomized, Placebo-Controlled, Double-Blind, Multicenter TrialAtte Meretoja, Stephen M. Davis, Leonid Churilov et al.|International Journal of Stroke|2013Cited by 73
Endovascular Thrombectomy for Ischemic Stroke Increases Disability-Free Survival, Quality of Life, and Life Expectancy and Reduces CostBruce Campbell, Peter Mitchell, Leonid Churilov et al.|Frontiers in Neurology|2017Cited by 66